Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters.

Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters.

Item
http://www.wikidata.org/entity/Q34543979
Enhanced antitumor activity of realgar mediated by milling it to nanosize.Biopharmaceutics and therapeutic potential of engineered nanomaterials.In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7.Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery.The impact of dosing interval in a novel tandem oral dosing strategy: enhancing the exposure of low solubility drug candidates in a preclinical setting.Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment.Liquid chromatography/tandem mass spectrometry method for quantitative estimation of solutol HS15 and its applications.Dexibuprofen nanocrystals with improved therapeutic performance: fabrication, characterization, in silico modeling, and in vivo evaluation.
P2860

Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters.

Item
http://www.wikidata.org/entity/Q34543979
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Intravenous administration of ...... on pharmacokinetic parameters.
@ast
Intravenous administration of ...... on pharmacokinetic parameters.
@en
Intravenous administration of ...... on pharmacokinetic parameters.
@nl
type
label
Intravenous administration of ...... on pharmacokinetic parameters.
@ast
Intravenous administration of ...... on pharmacokinetic parameters.
@en
Intravenous administration of ...... on pharmacokinetic parameters.
@nl
prefLabel
Intravenous administration of ...... on pharmacokinetic parameters.
@ast
Intravenous administration of ...... on pharmacokinetic parameters.
@en
Intravenous administration of ...... on pharmacokinetic parameters.
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P1433
P1476
Intravenous administration of ...... on pharmacokinetic parameters
@en
P2093
P304
P31
P433
P478
P577
P698